JULIA WARREN, MD | 2024 PJCCF GRANT RECIPIENT
FELLOW PHYSICIAN, DEPARTMENT OF PEDIATRIC HEMATOLOGY-ONCOLOGY
Dr. Julia Warren, a New Jersey native, completed her undergraduate degree at the University of Chicago before going on to combined MD and PhD training at Washington University in St. Louis. She stayed to complete combined pediatric residency and pediatric hematology/oncology training as part of the Oliver Langenberger Physician-Scientist Training Program at Washington University. There, she studied the role of TP53 mutations in acute myeloid leukemia (AML), often seen in a devastating form of leukemia that develops after cancer therapies. She also defined a new genetic lesion that causes impaired blood cell formation by affecting mitochondrial energy production. She moved to CHOP/University of Pennsylvania in 2022 where she runs a research laboratory focused on both normal and malignant blood cell formation. Dr. Warren also sees patients in the Comprehensive Bone Marrow Failure Center and the Cancer Predisposition Program. She is especially thrilled to be part of a joint clinical working group bringing UPenn adult hematology/oncology physicians together with CHOP doctors interested in genetic changes that increase a patient’s risk for developing leukemia. Her current work aims to target difficult-to-treat AML subsets by using small molecules that target mitochondria-based energy production. The ultimate goal is to develop new therapies that can improve overall survival for patients with leukemia. Dr. Warren is deeply grateful for the support of the Precious Jules Childhood Cancer Foundation in furthering this line of research, and their commitment to supporting the pediatric cancer patient and research community.
ADAM KEBEDE, MD | 2023 PJCCF GRANT RECIPIENT
POSTDOCTORAL RESEARCH FELLOW, DEPARTMENT OF PEDIATRIC ONCOLOGY
DANA FARBER CANCER INSTITUTE, BOSTON
GRANT PERIOD: 11/01/2023-10/31/2024
GRANT AMOUNT RECEIVED: $50,000
“THE ROLE OF PPM1D TRUNCATING MUTATIONS IN DRIVING THE DEVELOPMENT OF PEDIATRIC DIFFUSE MIDLINE GLIOMAS”
LISA NISWANDER, MD | 2022 PJCCF GRANT RECIPIENT
FELLOW PHYSICIAN, PEDIATRIC HEMATOLOGY/ONCOLOGY
CHILDREN’S HOSPITAL OF PHILADELPHIA
GRANT PERIOD: 04/22/2022-04/21/2023
GRANT AMOUNT RECEIVED: $50,000
“MEK INHIBITION TO IMPROVE CAR T CELL IMMUNOTHERAPY FOR HIGH-RISK PEDIATRIC LEUKEMIA”
JULIE GUEST, MD | 2019 PJCCF GRANT RECIPIENT
FELLOW PHYSICIAN, PEDIATRIC HEMATOLOGY/ONCOLOGY
JOHN HOPKIN’S UNIVERSITY MEDICAL CENTER/NATIONAL INSTITUTE OF HEALTH
GRANT PERIOD: 11/1/2019-10/31/2020
GRANT AMOUNT RECEIVED: $35,000
“THE IMMUNOBIOLOGY OF BLINATUMOMAB RESPONSE AND RESISTANCE IN HIGH-RISK RELAPSEDPEDIATRIC B-ACUTE LYMPHOBLASTIC LEUKEMIA”
CAITLIN ELGARTEN, MD | 2018 PJCCF GRANT RECIPIENT
FELLOW PHYSICIAN, PEDIATRIC HEMATOLOGY/ONCOLOGY
CHILDREN’S HOSPITAL OF PHILADELPHIA
GRANT PERIOD: 11/1/2018-10/31/2019
GRANT AMOUNT RECEIVED: $30,000
“INVESTIGATING THE GUT MICROBIOME PRIOR TO HEMATOPOIETIC CELL TRANSPLANT AS A POTENTIAL TARGET TO MITIGATE GRAFT-VERSUS-HOST DISEASE”
RYAN SUMMERS, MD, FAAP | 2017 PJCCF GRANT RECIPIENT
CHIEF FELLOW, PEDIATRIC HEMATOLOGY/ONCOLOGY
AFLAC CANCER AND BLOOD DISORDERS CENTER. CHILDREN’S HEALTHCARE OF ATLANTA- EMORY UNIVERSITY SCHOOL OF MEDICINE
GRANT PERIOD: 11/01/2017 -10/31/2018
GRANT AMOUNT RECEIVED: $25,000
“THERAPEUTIC TARGETING OF MERKT AND BCL-2 IN EARLY PRECURSOR ALL.”
SUZANNE MACFARLAND, MD | 2016 PJCCF GRANT RECIPIENT
ATTENDING PHYSICIAN, PEDIATRIC HEMATOLOGY/ONCOLOGY
CHILDREN’S HOSPITAL OF PHILADELPHIA
GRANT PERIOD: 11/01/2016—10/31/2017
GRANT AMOUNT RECEIVED: $20,000
“IDENTIFICATION OF UNDERLYING GENETIC ABERRATIONS IN JUVENILE POLYPOSIS SYNDROME (JPS) AND MALIGNANCY IN GENOTYPE/PHENOTYPING”